Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
about
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignSolute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesCollective Infectious Units in VirusesHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Regulated Entry of Hepatitis C Virus into Hepatocytes.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus.Identification of Entry Factors Involved in Hepatitis C Virus Infection Based on Host-Mimicking Short Linear Motifs.Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term hostNew perspectives for preventing hepatitis C virus liver graft infection.Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.Viral effects on the content and function of extracellular vesicles.Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.Significance of HCV RNA monitoring in the era of new potent therapies.RACK1 controls IRES-mediated translation of viruses.Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin.Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape.A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.Editorial on "Broadly neutralizing antibodies abrogate established hepatitis C virus infection" published in Science Translational Medicine on 17th September 2014Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.The Serum Very-Low-Density Lipoprotein Serves as a Restriction Factor against Hepatitis C Virus Infection.Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication.Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release.HCV Receptors and Virus Entry
P2860
Q26779128-1FF139F8-7BA1-4AA6-BEF7-D88EABF6C242Q26801759-51031E7E-6C28-4478-8E9D-41F736F57B2AQ27928046-F1837F54-E5DB-4BFA-9809-4A97F1736F67Q29464175-B7046A34-8058-4097-BE6B-1C7093FED8A3Q30386551-88718A47-3324-48C9-B97A-583DF8236D44Q33753913-60C2E486-8414-45F9-9F51-63EDB0175C9DQ34481429-314DAD65-ACF2-454D-9A2A-5EC879AA8AEFQ35598686-C429C7F8-7F38-4E3A-B6D6-CE1AEE4033EDQ35602911-5E0D2D2E-B2BA-4E52-BD7C-9CFE34D9B400Q35745457-5D90DC3B-C2A1-4DFB-950D-3B479EB6D8AAQ35890093-7E010E24-0934-4377-B009-2673BB9228FFQ36113029-EBE6EDFA-4313-41A8-A4D9-6C2A891330D1Q36262482-8952BF2A-18DA-4B53-96CC-1B1D9FE12058Q36682313-B60F196C-9065-4903-984C-0DC85847BBABQ36765305-BC915BD0-935B-4C6F-B48E-D7B15189D639Q37015805-AECF0CBB-9A81-4586-9803-6DEB8B253256Q37560723-A1391958-E1DF-4646-A0D9-E43730FEF5B1Q38666881-AFDC1B63-9A5F-408A-A904-967C090BA7F0Q38856649-9E5EEE98-DF2B-477D-9D57-BE416AA8A47CQ38899447-25AFE585-5386-4884-8B0F-EFE29B808772Q38938490-46288D94-99AE-46D6-BE4E-792994A405B0Q38945754-7782BF36-4613-47C3-8080-B17C48A75B44Q39026171-4A607177-C97B-46F0-8902-702FF42ADDC6Q39483891-4EA77060-7121-4BA6-930F-0518DD8CF4EBQ40271516-6141FFF9-C5F7-420B-806A-52D0FF0FBAB9Q40278524-8669FAC3-8297-4DE7-B6E1-46BB6F54124AQ40334457-E946BF2A-2EAE-4B90-AA27-6BD4B232A368Q40858663-9A5FDC29-5E8B-496D-91CE-723B67B5447CQ41033867-19BF208E-22CB-4B39-9102-09FE6230E78DQ41295530-746FE45D-ECFF-4FC7-B9BC-03C0A5D90E81Q41488466-EA294C90-3941-4116-8A1C-B47A5A863985Q52657367-4B9796E2-FB41-459F-B74E-8E2AD6342A4DQ57564402-76BD1AD2-A409-43B3-9E2E-332132E1ADDF
P2860
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@ast
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@en
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@nl
type
label
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@ast
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@en
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@nl
prefLabel
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@ast
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@en
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@nl
P2093
P2860
P50
P3181
P1433
P1476
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents
@en
P2093
Arvind H Patel
Eric Soulier
François Habersetzer
Heidi Barth
Isabel Fofana
Laura Heydmann
Michel Doffoël
Thomas F Baumert
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1004128
P407
P577
2014-05-15T00:00:00Z